Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001489192 | SCV001693729 | likely benign | Neuroblastoma, susceptibility to, 3 | 2020-11-13 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255558 | SCV002528393 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-22 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002255558 | SCV002704355 | likely benign | Hereditary cancer-predisposing syndrome | 2022-08-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003992414 | SCV004811647 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | ALK: BP4, BP7 |